April 25, 2022 Bausch + Lomb Presents Data from First Pivotal Phase 3 Trial of Investigational Treatment NOV03 (Perfluorohexyloctane) at the American Society of Cataract and Refractive Surgery Annual Meeting
Bausch + Lomb Will Present New Scientific Data During the American Society of Cataract and Refractive Surgery Annual Meeting “Bausch + Lomb is committed to supporting continuous scientific exchange designed to help surgeons get the most out of our current technologies and better understand the potential of those in our pipeline,”…